Company record · BRTX · Services-Misc Health & Allied Services, NEC
BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc.'s chief financial officer on the record is Anna Skowron, effective August 27, 2026, per the filing record.
The record holds 1 verified CFO change for BioRestorative Therapies, Inc. from Form 8-K filings, filed September 2, 2026 and its 10-K filed March 26, 2026, where no CFO signature could be established.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Anna Skowron |
| Title as printed | Chief Financial Officer and Treasurer |
| Basis | Latest move: transition, 8-K filed September 2, 2026 |
Seat timeline
2Every verified record for this seat, newest first, dated as the filing states it.
2026-09-02Transition
BioRestorative Therapies, Inc. CFO transition: Anna Skowron to succeed Katharyn Fieldeffective August 27, 2026 · 8-K filed September 2, 2026 · sec.gov, Item 5.02
2026-03-2610-K signature
CFO signature not established from the annual report
10-K filed March 26, 2026 · sec.gov
Company
| Ticker | BRTX |
|---|---|
| SEC CIK | 0001505497 |
| Industry (SIC) | Services-Misc Health & Allied Services, NEC (8090) |
| Roster note | From the 10-K filed 2026-03-26: signer name "Robert E. Kristal" is not in the signature section. |
Same industry on the record
1Other companies the roster files under SIC “Services-Misc Health & Allied Services, NEC”.
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.